BRIEF-Tianjin Development Says Tianjin Lisheng Pharmaceutical's Qtrly Net Profit Attributable Rmb44.4 Mln

April 24 (Reuters) - Tianjin Development Holdings Ltd :

* TIANJIN LISHENG PHARMACEUTICAL'S QTRLY TOTAL OPERATING INCOME RMB434.5 MILLION VERSUS RMB393.8 MILLION

* TIANJIN LISHENG PHARMACEUTICAL QTRLY NET PROFIT ATTRIBUTABLE RMB44.4 MILLION VERSUS RMB40.9 MILLION Source text for Eikon: Further company coverage: